Form D · Other Health Care
Acuity EyeCare Rollover, LLC
Dallas, TX · CIK 0001702759
Offering snapshot reported Apr 6, 2017 · SEC filing
- Reported sold
- $5.7M Offering amount: $5.7M
- Investors reported
- 12 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Mar 27, 2017 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Apr 6, 2017 | Initial | $5,698,943 | No comparison | 12 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-284254
Source: Form D, filed Apr 6, 2017. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Glenn W. Askew Iii | Director, Executive |
| Jeff Browning | Director |
| Jim Denny | Director |
| F. Barron Fletcher Iii | Director, Executive |
| Jeff S. Fronterhouse | Director, Executive |
| George Gebhardt | Director |
| Charles Matthews | Director, Executive |
| Warren Meyer | Director |
| Douglas C. Shepard | Executive |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
3889 Maple Avenue Parkland Hall, Suite 220
Dallas, TX, 75219
Dallas, TX, 75219